BKCG BNY Mellon Concentrated Growth ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| NVDA | 9.87% |
| AMZN | 7.42% |
| GOOG | 7.31% |
| ASML | 6.55% |
| MSFT | 6.10% |
| AAPL | 5.13% |
| NA | 4.60% |
| MA | 4.36% |
| LLY | 4.25% |
| META | 4.16% |
ETF Analysis
Fund Overview
BNY Mellon Concentrated Growth ETF (BKCG) currently reports 25 stock positions (subject to change), placing it in the selectively concentrated range by holdings breadth. The top line-up is NVDA (9.87%), AMZN (7.42%), GOOG (7.31%), with NVDA as the largest single weight at 9.87%. Together, the top three holdings account for 24.60%, which suggests a more balanced distribution of weight across the portfolio, reducing single-name sensitivity at the top. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.
Profitability & Capital Efficiency
On a capital return basis, ROIC is 43.04%, WACC is 11.33%, and the economic spread is 31.70%. On balance, the portfolio's businesses are compounding at rates that meaningfully exceed what capital costs would otherwise allow. Supporting metrics show ROE at 55.23% and ROA at 16.08%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
From a pricing standpoint, the portfolio sits at trailing P/E of 28.87, forward P/E of 23.52, PEG of 1.78. The gap between trailing and forward multiples is meaningful but not wide — the market appears to be pricing a constructive but controlled earnings trajectory. The growth-adjusted multiple is neither a strong buy signal nor a clear warning — it sits in the range where execution quality will determine whether the price is ultimately justified. A current ratio of 1.89 suggests the holdings have sufficient short-term liquidity without excess. In total, the multiple and liquidity readings describe a portfolio where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.
Margins & Cash Generation
Stripping to unit economics, gross margin sits at 62.90%, operating margin at 22.85%, and free cash flow margin at 26.16%. Gross margins are exceptional, reflecting strong pricing power and a defensible cost structure. The operating margin reading is constructive, suggesting management teams are managing overhead costs effectively. The portfolio's free cash flow margin is exceptional, pointing to capital-light businesses with strong reinvestment optionality. Together, these margin readings describe a portfolio of businesses that protect profitability at every layer of the income statement.
Growth & Forward Outlook
Revenue trends and analyst expectations together suggest: TTM revenue growth of 18.20% indicating steady top-line growth at the portfolio level, while the estimated 12-month price change of 31.87%, where consensus targets imply substantial appreciation potential over the next 12 months. At 22.8%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. There is always distance between what is reported and what is priced; the question of whether that distance is closing or widening is what makes the setup interesting. In either direction, the fundamental driver of returns will be whether the underlying businesses can sustain the trajectory that is already being priced. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyThe aggregate picture across capital efficiency, valuation, growth, and cash generation builds a compelling case.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.